Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauschild

Showing results (1091-1100 of 1,351) with videos related to

Pageof 136
Sort By:
The Lancet. Oncology|May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.
Journal of Animal Science|December 6, 2025
Effects of precision feeding and functional amino acid supplementation on Salmonella-challenged growing pigs under poor housing conditionsPedro Righetti Arnaut, Graziela Alves da Cunha Valini, Ismael França, et al.
Journal of Natural Products|November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory ActivityElena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
Journal of Medical Internet Research|September 11, 2020
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey StudyRoman C Maron, Jochen S Utikal, Achim Hekler, et al.
Journal of Animal Science|November 24, 2022
Effects of lowering dietary protein content without or with increased protein-bound and feed-grade amino acids supply on growth performance, body composition, metabolism, and acute-phase protein of finishing pigs under daily cyclic heat stressMarllon José Karpeggiane de Oliveira, Antonio Diego Brandão Melo, Danilo Alves Marçal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trialJ Guo, R D Carvajal, R Dummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Pageof 136

Showing results (1091-1100 of 1,351) with videos related to

Sort By:
Pageof 136
The Lancet. Oncology|May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.
Journal of Animal Science|December 6, 2025
Effects of precision feeding and functional amino acid supplementation on Salmonella-challenged growing pigs under poor housing conditionsPedro Righetti Arnaut, Graziela Alves da Cunha Valini, Ismael França, et al.
Journal of Natural Products|November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory ActivityElena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III studyM F Avril, S Aamdal, J J Grob, et al.
Journal of Medical Internet Research|September 11, 2020
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey StudyRoman C Maron, Jochen S Utikal, Achim Hekler, et al.
Journal of Animal Science|November 24, 2022
Effects of lowering dietary protein content without or with increased protein-bound and feed-grade amino acids supply on growth performance, body composition, metabolism, and acute-phase protein of finishing pigs under daily cyclic heat stressMarllon José Karpeggiane de Oliveira, Antonio Diego Brandão Melo, Danilo Alves Marçal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trialJ Guo, R D Carvajal, R Dummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Pageof 136